Listen on the go
CORRECT!
Next question
touchIMMUNOLOGY touchIMMUNOLOGY
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Immunology

    Immunology Content

    touchEXPERT BRIEFING
    UCB, making a difference in immunology
    For HCPs in: Global, excluding US and France
    View Time: 18 mins Sponsored content

    Watch Drs Ronald Vender, Richard Warren and Xenofon Baraliakos discuss UCB’s contributions to the treatment of immunological disease.

     

    GL-DA-2400232
    Date of Preparation: October 2024
    Immunology
    Breakthrough treatments for hereditary angioedema revealed at EAACI 2024

    Managing hereditary angioedema effectively remains a significant challenge, but recent clinical trials presented at EAACI 2024, in Valencia, Spain, have shown promising advancements in treatment options.

    Allergic Conditions, Dermatological Conditions, Immunology, Haematological Disorders, Urticaria
    Watch Time: 52 mins
    touchPANEL DISCUSSION
    Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
    CE/CME ACCREDITED Prof. Dr Vito Sabato, Dr Sigurd Broesby-Olsen, Prof. Prithviraj Bose Translations available:

    Multidisciplinary experts discuss the diagnosis and management of patients with systemic mastocytosis.

    Learning objectives
    Learning Objectives
    • Describe the signs, symptoms and diagnostic pathway for systemic mastocytosis
    • Explain how to apply personalized treatment strategies using a multidisciplinary approach to effectively manage systemic mastocytosis
    • Recall the latest data for new and emerging treatments for systemic mastocytosis and evaluate their potential impact on the clinical management of systemic mastocytosis in the future
    Haematological Disorders, Immunology
    Watch Time: 48 mins
    touchMDT
    Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team
    CE/CME ACCREDITED Prof. Michael Jordan, Dr Kate Kernan, Dr Eric Gars, Prof. Rob MacLaren Translations available:

    Multidisciplinary experts discuss the diagnosis and management of haemophagocytic lymphohistiocytosis (HLH)

    Learning objectives
    Learning Objectives
    • Describe the characteristic clinical and laboratory findings of HLH, and the confirmatory diagnostic tests
    • Explain the identification of predisposing conditions and acute triggers associated with HLH and how these affect treatment selection and monitoring
    • Implement effective multidisciplinary strategies for the diagnosis, monitoring and management of HLH in the critical care setting
    Respiratory Disorders, Immunology
    Watch Time: 31 mins
    touchEXPERT OPINIONS
    Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions
    CE/CME ACCREDITED Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono Translations available:

    Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

    Learning objectives
    Learning Objectives
    • Describe the pathogenesis of BOS and the burden on patients post-lung transplantation
    • Apply practical guidance to the diagnosis of BOS after lung transplantation
    • Evaluate the current and emerging treatment options for BOS in lung transplant recipients
    Paediatric Dermatology, Atopic Dermatitis, Dermatological Conditions, Immunology
    Watch Time: 38 mins
    touchPANEL DISCUSSION
    Paediatric atopic dermatitis: Evolving strategies for improved management
    CE/CME ACCREDITED Dr Elaine Siegfried, Assist. Prof. Nives Pustišek, Prof. Andreas Wollenberg

    Watch three experts discuss how they manage moderate-to-severe atopic dermatitis in children.

    Learning objectives
    Learning Objectives
    • Recognize the burden of atopic dermatitis in children, their families and caregivers and its impact on quality of life, particularly in moderate-to-severe disease
    • Summarize the latest data for systemic treatment options in children and adolescents with moderate-to-severe atopic dermatitis
    • Assess how continuity of care in children and adolescents impacts long-term symptom control
    Immuno-oncology, Immunology, Haematological Disorders
    Developed by Touch
    Tumour-selective targeted delivery of antibody-cytokine fusion proteins: Jamie Spangler, AACR 2023
    Watch Time: 7 mins

    Antibody-cytokine fusion proteins are a promising immunotherapy that could overcome off-target immune cell activation and the short serum half-life associated with low-dose interleukin-2 treatment. We were delighted to talk with Dr. Jamie Spangler (Johns Hopkins University, Baltimore, MD, USA) around the rationale for fusing cytokines to anti-cytokine antibodies in targeted therapy, the improved therapeutic efficacy […]

    Immunology
    Foreword – touchREVIEWS in RMD Vol 1 Issue 2 – 2022

    Welcome to the latest issue of touchREVIEWS in RMD, which aims to provide healthcare professionals with a wide range of topical articles in the field of rheumatic and musculoskeletal disorders. We begin with an expert interview in which Victoria Furer describes a study on the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination […]

    Allergic Conditions, Immunology
    Developed by Touch
    Andreas Recke, EAACI 2022: Lanadelumab in the Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency
    Watch Time: 6 mins

    The ENABLE study (ClinicalTrials.gov Identifier: NCT04130191) is an observational study, investigating the effectiveness of lanadelumab in real-life use in patients with hereditary angioedema with C1 inhibitor deficiency (HAE-C1-1NH). touchIMMUNOLOGY were delighted to speak with Dr. Andreas Recke (University of Lübeck, Lübeck, Germany) to discuss the aims, design and findings from his interim analysis of the […]

    In Partnership with...
    Useful Links:
    About us Society Partners Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
    Connect With Us:

    Other websites from Touch Medical Media:

    touchONCOLOGY
    touchOPHTHALMOLOGY
    touchENDOCRINOLOGY
    touchNEUROLOGY
    touchCARDIO
    touchRESPIRATORY
    touchIMMUNOLOGY
    touchINFECTIOUS DISEASES
    touchHAEMATOLOGY
    touchDERMATOLOGY

    Copyright® 2024 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

    touchIMMUNOLOGY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
    Close Popup